Expression of protein disulfide isomerase A3 precursor in colorectal cancer
Authors Yang Z, Liu J, Shi Q, Chao Y, Di Y, Sun J, Zhang J, Huang L, Guo H, He C
Received 18 October 2017
Accepted for publication 17 April 2018
Published 19 July 2018 Volume 2018:11 Pages 4159—4166
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Geoffrey Pietersz
Zhaowei Yang,1 Juan Liu,2 Qinghong Shi,1 Yang Chao,3 Yanqing Di,3 Jing Sun,3 Jiebing Zhang,3 Lihong Huang,4 Honghua Guo,3 Chengyan He1
1Laboratory Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, China; 2Department of Digestive Internal Medicine, Qian Wei Hospital of Jilin Province, Changchun, China; 3Department of Digestive Internal Medicine, China-Japan Union Hospital of Jilin University, Changchun, China; 4Department of Geriatrics, China-Japan Union Hospital of Jilin University, Changchun, China
Introduction: Over 20% of colorectal cancer (CRC) patients seek medical attention for the first time when they are in the advanced stages of CRC. Thus, early and reliable detection of CRC is critical to early diagnosis of CRC. Protein disulfide isomerase A3 precursor (PDIA3) has been implicated in various types of cancers. However, little is known about PDIA3 in CRC.
Methods: In this study, we screened PDIA3 expression in CRC tissues and cell lines. Small interfering RNA (siRNA) was introduced into SW480 cells to knockdown PDIA3 expression. The effect of PDIA3 in cell growth was evaluated.
Results: Significant upregulation of PDIA3 expression was found in CRC tissues as compared with adjacent non-cancer tissues, and was found in established CRC cell lines (SW480, HCT116, CACO2, NCM460 and HT-29). In SW480 cells, knockdown of PDIA3 expression with siRNA resulted in subcellular morphological change, reduced cell proliferation and increased apoptosis.
Conclusion: PDIA3 inhibition could suppress CRC, likely through inducing apoptosis. PDIA3 could be a potential therapeutic target for CRC.
Keywords: PDIA3, colorectal cancer, proteomics, siRNA, apoptosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]